Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalasemia Major

NCT02984475 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT02984475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02984475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalasemia Major
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2016
Completion date
April 30, 2019
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

beta thalassemia major anemia